Skip to main content
Erschienen in: Journal of Endocrinological Investigation 9/2015

01.09.2015 | Original Article

The prevalence of benign breast diseases in patients with nodular goiter and Hashimoto’s thyroiditis

verfasst von: C. Anil, T. Guney, A. Gursoy

Erschienen in: Journal of Endocrinological Investigation | Ausgabe 9/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The evidence regarding association between thyroid disorders and benign and malignant breast diseases is increasing. The studies exploring the relationship between thyroid and breast diseases usually have focused on thyroid autoimmunity and functions in patients with breast pathologies. In this study, we aimed to reveal the frequency of benign breast conditions in patients with nodular thyroid disease (NTD) and Hashimoto’s thyroiditis (HT).

Methods

Seventy-one women with NTD, ninety-five women with HT and seventy-two healthy people as a control group were included in the study. Serum thyroid-stimulating hormone, free triiodothyronine, free thyroxine, and thyroid peroxidase autoantibody levels were measured, and thyroid and breast ultrasonography were performed by a single operator in order to determine thyroid and breast pathology.

Results

Benign breast diseases were detected in 54.9 % of patients with NTD, in 47.4 % of those with HT, and 29.2 % of control group in the study (p < 0.01 for nodular and Hashimoto groups versus control group). Simple cyst was found to be the most frequent pathology among benign breast diseases; fibrocystic changes, mixed lesions, benign solid mass, ductal ectasia, and complex cyst followed it. No significant relation was found regarding thyroid function and autoimmunity in patients diagnosed with benign breast disease (p > 0.05).

Conclusions

The results of our study support the association between benign breast diseases and thyroid diseases. An important implication of this finding may be demonstration of the necessity of scanning for potential breast pathology in women with nodular or autoimmune thyroid disease in clinical practice.
Literatur
1.
Zurück zum Zitat Salvatore D, Davies TF, Schlumberger MJ et al (2011) Thyroid physiology and diagnostic evaluation of patients with thyroid disorders. In: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM (eds) Williams Textbook of Endocrinology, 12th edn. Elsevier Saunders, Philadelphia, pp 327–478CrossRef Salvatore D, Davies TF, Schlumberger MJ et al (2011) Thyroid physiology and diagnostic evaluation of patients with thyroid disorders. In: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM (eds) Williams Textbook of Endocrinology, 12th edn. Elsevier Saunders, Philadelphia, pp 327–478CrossRef
2.
Zurück zum Zitat Adamopoulos DA, Vassilaros S, Kapolla N et al (1986) Thyroid disease in patients with benign and malignant mastopathy. Cancer 57:125–128CrossRefPubMed Adamopoulos DA, Vassilaros S, Kapolla N et al (1986) Thyroid disease in patients with benign and malignant mastopathy. Cancer 57:125–128CrossRefPubMed
3.
Zurück zum Zitat Giustarini E, Pinchera A, Fierabracci P et al (2006) Thyroid autoimmunity in patients with malignant and benign breast diseases before surgery. Eur J Endocrinol 154:645–649CrossRefPubMed Giustarini E, Pinchera A, Fierabracci P et al (2006) Thyroid autoimmunity in patients with malignant and benign breast diseases before surgery. Eur J Endocrinol 154:645–649CrossRefPubMed
4.
Zurück zum Zitat Vassilopoulou-Sellin R, Palmer L, Taylor S et al (1999) Incidence of breast carcinoma in women with thyroid carcinoma. Cancer 85:696–705CrossRefPubMed Vassilopoulou-Sellin R, Palmer L, Taylor S et al (1999) Incidence of breast carcinoma in women with thyroid carcinoma. Cancer 85:696–705CrossRefPubMed
5.
Zurück zum Zitat Saraiva PP, Figueiredo NB, Padovani CR et al (2005) Profile of thyroid hormones in breast cancer patients. Braz J Med Biol Res 38:761–765CrossRefPubMed Saraiva PP, Figueiredo NB, Padovani CR et al (2005) Profile of thyroid hormones in breast cancer patients. Braz J Med Biol Res 38:761–765CrossRefPubMed
6.
Zurück zum Zitat Brunn J, Block U, Ruf G et al (1981) Volumetric Analysis of Thyroid Lobes by Realtime Ultrasound. Dtsch Med Wochenschr 106:1338–1340CrossRefPubMed Brunn J, Block U, Ruf G et al (1981) Volumetric Analysis of Thyroid Lobes by Realtime Ultrasound. Dtsch Med Wochenschr 106:1338–1340CrossRefPubMed
7.
Zurück zum Zitat Mehta T (2003) Current uses of ultrasound in the evaluation of breast. Radiol Clin North Am 41:841–856CrossRefPubMed Mehta T (2003) Current uses of ultrasound in the evaluation of breast. Radiol Clin North Am 41:841–856CrossRefPubMed
8.
Zurück zum Zitat Baskin B, Hadar O, Tashman S et al (2005) Sonographic diagnosis of breast cancer. In: Roses DF (ed) Breast Cancer, 2nd edn. Elsevier Churchill Livingstone, Philadelphia, pp 247–269CrossRef Baskin B, Hadar O, Tashman S et al (2005) Sonographic diagnosis of breast cancer. In: Roses DF (ed) Breast Cancer, 2nd edn. Elsevier Churchill Livingstone, Philadelphia, pp 247–269CrossRef
9.
Zurück zum Zitat Giani C, Fierabracci P, Bonacci R et al (1996) Relationship between breast cancer and thyroid disease: relevance of autoimmune thyroid disorders in breast malignancy. J Clin Endocrinol Metab 81:990–994PubMed Giani C, Fierabracci P, Bonacci R et al (1996) Relationship between breast cancer and thyroid disease: relevance of autoimmune thyroid disorders in breast malignancy. J Clin Endocrinol Metab 81:990–994PubMed
10.
Zurück zum Zitat Smyth PPA, Shering SG, Kilbane MT et al (1998) Serum thyroid peroxidase autoantibodies, thyroid volume, and outcome in breast carcinoma. J Clin Endocrinol Metab 83:2711–2716PubMed Smyth PPA, Shering SG, Kilbane MT et al (1998) Serum thyroid peroxidase autoantibodies, thyroid volume, and outcome in breast carcinoma. J Clin Endocrinol Metab 83:2711–2716PubMed
11.
12.
Zurück zum Zitat Bhargav PRK, Mishra A, Agarwal G et al (2009) Prevalence of hypothyroidism in benign breast disorders and effect of thyroxine replacement on the clinical outcome. World J Surg 33:2087–2093CrossRefPubMed Bhargav PRK, Mishra A, Agarwal G et al (2009) Prevalence of hypothyroidism in benign breast disorders and effect of thyroxine replacement on the clinical outcome. World J Surg 33:2087–2093CrossRefPubMed
13.
Zurück zum Zitat Prinzi N, Baldini E, Sorrenti S et al (2014) Prevalence of breast cancer in thyroid diseases: results of a cross-sectional study of 3921 patients. Breast Cancer Res Treat 144(3):683–688CrossRefPubMed Prinzi N, Baldini E, Sorrenti S et al (2014) Prevalence of breast cancer in thyroid diseases: results of a cross-sectional study of 3921 patients. Breast Cancer Res Treat 144(3):683–688CrossRefPubMed
14.
Zurück zum Zitat Hardefeldt PJ, Eslick GD, Edirimanne S (2012) Benign thyroid disease is associated with breast cancer: a meta-analysis. Breast Cancer Res Treat 133(3):1169–1177CrossRefPubMed Hardefeldt PJ, Eslick GD, Edirimanne S (2012) Benign thyroid disease is associated with breast cancer: a meta-analysis. Breast Cancer Res Treat 133(3):1169–1177CrossRefPubMed
15.
Zurück zum Zitat Tosovic A, Becker C, Bondeson AG et al (2012) Prospectively measured thyroid hormones and thyroid peroxidase antibodies in relation to breast cancer risk. Int J Cancer 131(9):2126–2133CrossRefPubMed Tosovic A, Becker C, Bondeson AG et al (2012) Prospectively measured thyroid hormones and thyroid peroxidase antibodies in relation to breast cancer risk. Int J Cancer 131(9):2126–2133CrossRefPubMed
16.
Zurück zum Zitat Muller I, Pinchera A, Fiore E et al (2011) High prevalence of breast cancer in patients with benign thyroid diseases. J Endocrinol Invest 34(5):349–352CrossRefPubMed Muller I, Pinchera A, Fiore E et al (2011) High prevalence of breast cancer in patients with benign thyroid diseases. J Endocrinol Invest 34(5):349–352CrossRefPubMed
17.
Zurück zum Zitat Nio Y, Iguchi C, Itakura M et al (2009) High incidence of synchronous or metachronous breast cancer in patients with malignant and benign thyroid tumor or tumor-like disorders. Anticancer Res 29(5):1607–1610PubMed Nio Y, Iguchi C, Itakura M et al (2009) High incidence of synchronous or metachronous breast cancer in patients with malignant and benign thyroid tumor or tumor-like disorders. Anticancer Res 29(5):1607–1610PubMed
18.
Zurück zum Zitat Farahati J, Roggenbuck D, Gilman E et al (2012) Anti-thyroid peroxidase antibodies are associated with the absence of distant metastases in patients with newly diagnosed breast cancer. Clin Chem Lab Med 50(4):709–714CrossRefPubMed Farahati J, Roggenbuck D, Gilman E et al (2012) Anti-thyroid peroxidase antibodies are associated with the absence of distant metastases in patients with newly diagnosed breast cancer. Clin Chem Lab Med 50(4):709–714CrossRefPubMed
19.
Zurück zum Zitat Ditsch N, Mayr D, Lenhard M et al (2012) Correlation of thyroid hormone, retinoid X, peroxisome proliferator-activated, vitamin D and oestrogen/progesterone receptors in breast carcinoma. Oncol Lett 4(4):665–671PubMedCentralPubMed Ditsch N, Mayr D, Lenhard M et al (2012) Correlation of thyroid hormone, retinoid X, peroxisome proliferator-activated, vitamin D and oestrogen/progesterone receptors in breast carcinoma. Oncol Lett 4(4):665–671PubMedCentralPubMed
20.
Zurück zum Zitat Ditsch N, Toth B, Himsl I et al (2013) Thyroid hormone receptor (TR) alpha and TR beta expression in breast cancer. Histol Histopathol 28(2):227–237PubMed Ditsch N, Toth B, Himsl I et al (2013) Thyroid hormone receptor (TR) alpha and TR beta expression in breast cancer. Histol Histopathol 28(2):227–237PubMed
21.
Zurück zum Zitat Govindaraj V, Yaduvanshi NS, Krishnamachar H et al (2012) Expression of thyroid-stimulating hormone receptor, octamer-binding transcription factor 4, and intracisternal A particle-promoted polypeptide in human breast cancer tissues. Horm Mol Biol Clin Investig 9(3):173–178PubMed Govindaraj V, Yaduvanshi NS, Krishnamachar H et al (2012) Expression of thyroid-stimulating hormone receptor, octamer-binding transcription factor 4, and intracisternal A particle-promoted polypeptide in human breast cancer tissues. Horm Mol Biol Clin Investig 9(3):173–178PubMed
Metadaten
Titel
The prevalence of benign breast diseases in patients with nodular goiter and Hashimoto’s thyroiditis
verfasst von
C. Anil
T. Guney
A. Gursoy
Publikationsdatum
01.09.2015
Verlag
Springer International Publishing
Erschienen in
Journal of Endocrinological Investigation / Ausgabe 9/2015
Elektronische ISSN: 1720-8386
DOI
https://doi.org/10.1007/s40618-015-0269-8

Weitere Artikel der Ausgabe 9/2015

Journal of Endocrinological Investigation 9/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.